Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4659-4671

  Rangger, Christine ^a   Helbok, Anna ^a   Sosabowski, Jane ^b   Kremser, Christian ^a   Koehler, Gottfried ^c   Prassl, Ruth ^d,e   Andreae, Fritz ^f   Virgolini, Irene J ^a   Von Guggenberg, Elisabeth ^a   Decristoforo, Clemens ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^f piCHEM Research and Development   (Austria)

Author keywords

Dual targeting; Liposomal nanoparticles; Multifunctionality; Radiolabeling; Tumor imaging

Indexed keywords

1,2 DIMYRISTOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N DIETHYLENETRIAMINEPENTAACETIC ACID; 2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; ARGINYLGLYCYLASPARTIC ACID; BETA3 INTEGRIN; DUAL PEPTIDE CONJUGATED MULTIFUNCTIONAL LIPOSOMAL NANOPARTICLE; GADOLINIUM; GADOLINIUM ARGINYLGLYCYLASPARTIC ACID LIPOSOMAL NANOPARTICLE; GADOLINIUM ARGINYLGLYCYLASPARTIC ACID SUBSTANCE P BUILDING BLOCK CONJUGATE LIPOSOMAL NANOPARTICLE; GADOLINIUM SUBSTANCE P BUILDING BLOCK LIPOSOMAL NANOPARTICLE; INDIUM; INDIUM ARGINYLGLYCYLASPARTIC ACID LIPOSOMAL NANOPARTICLE IN 111; INDIUM ARGINYLGLYCYLASPARTIC ACID SUBSTANCE P BUILDING BLOCK CONJUGATE LIPOSOMAL NANOPARTICLE IN 111; INDIUM SUBSTANCE P BUILDING BLOCK LIPOSOMAL NANOPARTICLE IN 111; LIPID; LIPOSOME; MACROGOL DERIVATIVE; NANOPARTICLE; NEUROKININ 1 RECEPTOR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; RHODAMINE B; RHODAMINE B ARGINYLGLYCYLASPARTIC ACID LIPOSOMAL NANOPARTICLE; RHODAMINE B ARGINYLGLYCYLASPARTIC ACID SUBSTANCE P BUILDING BLOCK CONJUGATE LIPOSOMAL NANOPARTICLE; RHODAMINE B SUBSTANCE P BUILDING BLOCK LIPOSOMAL NANOPARTICLE; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL INTERACTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CT SPECT SCANNER; DERIVATIZATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MELANOMA; MICRO SPECT CT IMAGING; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PROTEIN BINDING; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT; ZETA POTENTIAL;

ANIMALIA; MUS MUSCULUS;

DUAL-TARGETING; LIPOSOMAL NANOPARTICLES; MULTIFUNCTIONALITY; RADIOLABELING; TUMOR IMAGING;

ANIMALS; CELL LINE; FEMALE; LIPOSOMES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; PEPTIDES; POLYETHYLENE GLYCOLS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84889570832     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51927     Document Type: Article

References (39)

1. Li S, Goins B, Zhang L, Bao A. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug Chem. 2012;23:1322-1332.
2. Kalia M. Personalized oncology: recent advances and future challenges. Metabolism. 2013;62 Suppl 1:11-14.
3. Kircher MF, Hricak H, Larson SM. Molecular imaging for personalized cancer care. Mol Oncol. 2012;6:182-195.
4. Wender PA, Cooley CB, Geihe EI. Beyond cell penetrating peptides: designed molecular transporters. Drug Discov Today Technol. 2012;9: e49-e55.
5. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145-160.
6. Abuchowski A, Van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem. 1977;252:3578-3581.
7. Allen C, Dos Santos N, Gallagher R, et al. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep. 2002;22: 225-250.
8. Torchilin VP. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2011;63:131-135.
9. Lattin JR, Belnap DM, Pitt WG. Formation of eLiposomes as a drug delivery vehicle. Colloids Surf B Biointerfaces. 2012;89:93-100.
10. Shokeen M, Pressly ED, Hagooly A, et al. Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano. 2011;5:738-747.
11. Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med. 2002;8: 1335-1347.
12. Strijkers GJ, Kluza E, Van Tilborg GA, et al. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis. 2010;13:161-173.
13. Ruoslahti E, Pierschbacher MD. Arg-Gly-Asp: a versatile cell recognition signal. Cell. 1986;44:517-518.
14. Rangger C, Helbok A, Von Guggenberg E, et al. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles. Int J Nanomedicine. 2012;7:5889-5900.
15. Chen X, Park R, Hou Y, et al. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur J Nucl Med Mol Imaging. 2004;31:1081-1089.
16. Muñoz M, Rosso M, Coveñas R. The NK-1 receptor: a new target in cancer therapy. Curr Drug Targets. 2011;12:909-921.
17. Palma C. Tachykinins and their receptors in human malignancies. Curr Drug Targets. 2006;7:1043-1052.
18. Hennig IM, Laissue JA, Horisberger U, Reubi JC. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer. 1995;61:786-792.
19. Rosso M, Muñoz M, Berger M. The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer. ScientificWorldJournal. 2012;2012:381434.
20. Ogo H, Kuroyanagi N, Inoue A, et al. Human astrocytoma cells (U-87 MG) exhibit a specific substance P binding site with the characteristics of an NK-1 receptor. J Neurochem. 1996;67:1813-1820.
21. Liu Z, Jia B, Zhao H, Chen X, Wang F. Specific targeting of human integrin αvβ3 with 111In-labeled Abegrin™ in nude mouse models. Mol Imaging Biol. 2011;13:112-120.
22. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small. 2007;3:1840-1854.
23. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13: 238-252.
24. Helbok A, Decristoforo C, Dobrozemsky G, et al. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. J Liposome Res. 2010;20: 219-227.
25. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology. 1999;212:876-884.
26. Cheng HL, Wright GA. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med. 2006;55: 566-574.
27. Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;219: 316-333.
28. Liu Z, Wang F. Dual-targeted molecular probes for cancer imaging. Curr Pharm Biotechnol. 2010;11:610-619.
29. Takara K, Hatakeyama H, Ohga N, Hida K, Harashima H. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake. Int J Pharm. 2010;396:143-148.
30. Laginha K, Mumbengegwi D, Allen T. Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity. Biochim Biophys Acta, 2005;1711:25-32.
31. Saul JM, Annapragada AV, Bellamkonda RV. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release. 2006;114:277-287.
32. McAteer MA, Schneider JE, Ali ZA, et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol. 2008;28:77-83.
33. De Vries A, Kok MB, Sanders HM, Nicolay K, Strijkers GJ, Gruell H. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements. Contrast Media Mol Imaging. 2012;7: 68-75.
34. Trubetskoy VS, Berdichevsky VR, Efremov EE, Torchilin VP. On the possibility of the unification of drug targeting systems. Studies with liposome transport to the mixtures of target antigens. Biochem Pharmacol. 1987;36:839-842.
35. Kluza E, Jacobs I, Hectors SJ, et al. Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. J Control Release. 2012;158:207-214.
36. Kluza E, Van Der Schaft D, Hautvast P, et al. Synergistic targeting of αvβ3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett. 2010;10:52-58.
37. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li K. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998;4:623-626.
38. Li W, Su B, Meng S, et al. RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies. Eur J Radiol. 2011;80:598-606.
39. Flament J, Geffroy F, Medina C, et al. In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T. Magn Reson Med. 2013;69:179-187.